Skip to Content

Early and Managed Access Programmes

Start Date:
Tuesday, 24 October, 2017
End Date:
Thursday, 26 October, 2017 5:00am
Speciality:
Physical Medicine, Business Practice, Health & Nutrition
Website:
http://bit.ly/2vbHw6A

The Early and Managed Access Programmes Forum - The World's First and most Prestigious EMAP event - returns in October 2017, where industry leaders from Janssen, Bristol-Myers Squibb, Novartis, Incyte and Onconova will combine with Patient Advocacy Groups such as CLIMB and NCRI to address challenges at the very heart of this vital yet, complex, field.Patient demand for medication is only rising, with more Ophan and Rare diseases, and more pressure on the Pharmaceutical Industry to deliver patient treatments.

There has never been a more important time to ensure that you understand the risks and challenges associated with Early or Managed Access Programs and are prepared for the ethical and regulatory pressures that come with these front-line medical developments and access programs. The perfect environment to engage with Industry experts who have launched, managed and terminated EMAPs, this year's event will help your team feel confident in addressing the regulatory, ethical and management aspects of your E/MAP and ensure you feel secure in your next steps.

Location

179-199 Holland Park Ave London W11 4UL

Organizer Details

Conference organized by IQPC

LEVERAGING AI TO SCALE YOUR BUSINESS, DRIVE GROWTH AND IMPROVE CUSTOMER EXPERIENCE

Address:
129 Wilton Road
Phone:
+65 6722 9388
Email:
enquire@iqpc.co.uk

Medical conference data provided by Meetings4Docs | Report a problem

Image Gallery

Hide